ebook Munafa Stock Market Course + Intraday & FNO calls  

       

REGN announcements Regeneron Pharmaceuticals, Inc. announcements and dividends declared NASDAQ

Regeneron Pharmaceuticals, Inc. Complete list of announcements declared & dividend announcements by Regeneron Pharmaceuticals, Inc. REGN

Regeneron Pharmaceuticals, Inc. REGN listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Regeneron Pharmaceuticals, Inc. REGN

Regeneron Pharmaceuticals Stock: Analyst Estimates & Ratings
Despite Regeneron Pharmaceuticals’ underperformance relative to the broader market over the past year, Wall Street analysts maintain a bullish outlook about the stock’s prospects.
Announcement as on 25 February 2025

Regeneron Pharmaceuticals Reaches Analyst Target Price
In recent trading, shares of Regeneron Pharmaceuticals, Inc. (Symbol: REGN) have crossed above the average analyst 12-month target price of 3.21, changing hands for 3.35/share. When a stock reaches the target an analyst has set, the analyst logicall
Announcement as on 28 February 2024

Bull of the Day: Regeneron Pharmaceuticals (REGN)
Regeneron Pharmaceuticals REGN is a biotechnology company focused on the discovery, development and commercialization of treatments targeting serious medical conditions. The company boasts a number of market-leading drugs includin
Announcement as on 17 January 2024

Bull of the Day: Regeneron Pharmaceuticals (REGN)
Regeneron Pharmaceuticals REGN is a biotechnology company focused on the discovery, development and commercialization of treatments targeting serious medical conditions. The company boasts a number of market-leading drugs includin
Announcement as on 17 January 2024

Regeneron Pharmaceuticals Q3 Profit Decreases, but beats estimates
(RTTNews) - Regeneron Pharmaceuticals (REGN) released a profit for third quarter that decreased from the same period last year but beat the Street estimates.
Announcement as on 02 November 2023

Announcements by Regeneron Pharmaceuticals, Inc. first page | Next page |

REGN Regeneron Pharmaceuticals, Inc. current price & indicator signals

Moving Averages for Regeneron Pharmaceuticals, Inc.

  • 5Day Average: 731.33
  • 12Day Average: 747.17
  • 20Day Average: 722.66
  • 50Day Average: 646.55
  • 100Day Average: 607.74
  • 150Day Average: 587.58
  • 200Day Average: 598.91

REGN Indicators & signals

Indicator MACD (12,26,9)

732.92, 705.88, 34.12
Indicator MACD is in positive zone

Indicator ADX (14)

14.88, 26.83, 19.88
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 60
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of REGN Regeneron Pharmaceuticals, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
05 Fri Dec 2025 718.05 717.26 to 736.15 -0.66% 0.33 times
04 Thu Dec 2025 722.80 721.22 to 735.00 -0.12% 0.96 times
03 Wed Dec 2025 723.67 720.07 to 744.23 -2.47% 1.11 times
02 Tue Dec 2025 742.00 731.00 to 747.00 -1.08% 0.83 times
01 Mon Dec 2025 750.11 748.15 to 779.92 -3.86% 0.89 times
28 Fri Nov 2025 780.19 779.50 to 788.98 -0.56% 0.46 times
26 Wed Nov 2025 784.61 777.00 to 790.98 -0.34% 0.78 times
25 Tue Nov 2025 787.32 760.01 to 790.57 3.38% 1.08 times
24 Mon Nov 2025 761.58 756.64 to 773.13 0.75% 0.53 times
21 Fri Nov 2025 755.90 735.74 to 764.09 2.56% 1.28 times
20 Thu Nov 2025 737.00 720.02 to 753.51 4.87% 2.07 times
19 Wed Nov 2025 702.75 702.63 to 727.81 -3.11% 1.24 times

Videos related to: REGN announcements Regeneron Pharmaceuticals, Inc. announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

REGN announcements Regeneron Pharmaceuticals, Inc. announcements and dividends declared NASDAQ

 

Back to top